AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.722
+0.032 (4.62%)
At close: Jun 26, 2026, 4:00 PM EDT
0.704
-0.018 (-2.47%)
After-hours: Jun 26, 2026, 8:00 PM EDT
AEON Biopharma Employees
AEON Biopharma had 8 employees as of December 31, 2025. The number of employees increased by 3 or 60.00% compared to the previous year.
Employees
8
Change (1Y)
3
Growth (1Y)
60.00%
Revenue / Employee
n/a
Profits / Employee
-$7,513,750
Market Cap
18.99M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8 | 3 | 60.00% |
| Dec 31, 2024 | 5 | -5 | -50.00% |
| Dec 31, 2023 | 10 | 2 | 25.00% |
| Dec 31, 2022 | 8 | -12 | -60.00% |
| Dec 31, 2019 | 20 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 115 |
| Palatin Technologies | 29 |
| Lunai Bioworks | 29 |
| Lipocine | 14 |
| Werewolf Therapeutics | 14 |
| NewcelX | 12 |
| Cellectar Biosciences | 11 |
| Allarity Therapeutics | 8 |
AEON News
- 23 days ago - AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society - GlobeNewsWire
- 6 weeks ago - AEON Biopharma Reports First Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 weeks ago - AEON Biopharma Earnings release: Q1 2026 - Filings
- 6 weeks ago - AEON Biopharma Quarterly report: Q1 2026 - Filings
- 6 weeks ago - Aeon Biopharma management to meet virtually with Lake Street - TheFly
- 6 weeks ago - AEON Biopharma Slides: Corporate presentation - Filings
- 2 months ago - AEON Biopharma Proxy statement: Proxy filing - Filings
- 2 months ago - AEON Biopharma Proxy statement: Proxy filing - Filings